These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004482-15 Hirnaktivierung während Gedächtnisaufgaben bei Patienten mit Schizophrenie unter Behandlung von Ziprasidon oder Risperidon. Eine FMRT-Untersuchung. not-yet-due
Ongoing 2005-001017-17 µ-Opiatrezeptorvermittelte Dopaminfreisetzung bei Alkoholabhängigkeit: PET-Studien mit [18F]Fallypride not-yet-due
Ongoing 2005-002699-13 Modafinil in der Behandlung von Müdigkeit bei Tumorpatienten - eine randomisierte doppelblinde N=1 Studie not-yet-due
Not reported 2005-002983-27 Prospektive randomisierte Studie zur Untersuchung der Wirksamkeit der Photodynamischen Therapie bei aktinischen Keratosen 2008-02-27 due-trials
Ongoing 2005-003245-14 Neuronale Korrelate von dysfunktionellen Aufmerksamkeitskomponenten bei Patienten mit Schizophrenie: cholinerge Rezeptorsysteme und pharmakologische Therapie not-yet-due
Ongoing 2005-004218-34 Effect of extended-release niacin on myocardial blood flow and flow reserve in patients with coronary artery disease treated with statins not-yet-due
Ongoing 2006-005531-17 Xenon als Antidepressivum not-yet-due
Ongoing 2006-005567-26 Effects of deep brain stimulation of the nucleus accumbens on the dopaminergic activity in patients with Gilles-de-la-Tourette-syndrome not-yet-due
Ongoing 2007-000479-40 Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology not-yet-due
Not reported 2007-000871-41 Supportive versus Immunosuppressive Therapy for the treatment Of Progressive IgA Nephropathy 2015-02-28 due-trials
Completed, but no date Terminated 2007-001685-33 Prospective Comparison of Phenpocoumon (Marcumar) and Acetylsalicylic Acid (ASS) as to Progression of the Valvular and Coronary Calcification. bad-data
Not reported 2007-002765-12 Influence of the angiotensin receptor blocker Telmisartan on the red blood cell function and the microcirculatory perfusion (ITEM) 2009-01-13 due-trials
Ongoing 2008-000459-88 Prospective, randomized study of the efficacy of photodynamic therapy in actinic keratosis not-yet-due
Reported results 2008-005312-41 Perioperative chemotherapy with FOLFOX plus Cetuximab versus adjuvant FOLFOX plus Cetuximab for patients with resectable liver metastases of colorectal carcinoma 2015-02-24 due-trials
Ongoing 2008-006905-18 Pharmakotherapie kognitiver Defizite bei schizophrenen Störungen – Randomisierte placebokontrollierte Doppelblindstudie mit Pergolid versus Tolcapon not-yet-due
Listed as ongoing, but also has a completion date 2009-014373-41 A randomised Phase II trial of Imatinib (IM) versus Hydroxychloroquine (HCQ) and Imatinib (IM) for patients with Chronic Myeloid Leukaemia (CML) in Cytogenetic Response (CyR) with residual disease det... 2017-06-27 bad-data
Not reported 2009-015538-30 Effect of intranasal oxytocin on social approach in patients with social phobia and healthy control 2011-12-15 due-trials
Ongoing 2010-019884-12 Induction of Fibrosis Regression regarding Chronic Hepatitis B Infection not-yet-due
Ongoing 2010-021264-14 Vitamin K1 to slow vascular calcification in hemodialysis patients. not-yet-due
Not reported Terminated 2010-022679-71 Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation 2014-12-31 due-trials
Not reported 2010-023942-63 The safety and feasibility of delivering xenon to patients before and after coronary artery bypass graft implantation: a pilot study 2011-12-04 due-trials
Ongoing 2012-003858-81 Effect of Linagliptin therapy on myocardial diastolic function in patients with type 2 diabetes mellitus not-yet-due
Completed, but no date Terminated 2012-003859-12 Linagliptin as a modulator of vascular inflammation in patients with type 2 diabetes mellitus bad-data
Not reported Terminated 2012-005698-30 Impact of Xenon-anaesthesia on the renal function after partial nephrectomy - PaNeX: Partial Nephrectomy under Xenon 2016-02-15 due-trials
Ongoing 2013-001062-41 Neoadjuvant chemotherapy with Cabazitaxel in high risk prostate cancer patients prior to radical prostatectomy not-yet-due
Not reported 2013-001357-26 HIGH DOSE SUPPLEMENTATION OF SELENIUM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) IMPLANT SURGERY – A DOUBLE BLIND RANDOMISED CONTROLLED TRIAL 2017-11-28 due-trials
Ongoing 2013-002132-25 RUXOlitinib versus BEst Available Therapy in patients with high-risk polycythemia vera or high-risk essential thrombocythemia – The RUXO-BEAT Trial not-yet-due
Ongoing 2013-004644-28 Administration of Rifaximin to improve Liver Regeneration and Outcome following Major Liver Resection not-yet-due
Not reported Terminated 2014-000973-38 Xenon-inhalation: elimination of xenon and its effect on erythropoetin-levels in blood of healthy volunteers 2014-12-01 due-trials
Completed, but no date 2014-003810-96 Emergence times and airway reactions in general laryngeal mask airway anesthesia: a randomized multicenter controlled trial bad-data
Ongoing 2016-000048-32 Evaluation of the Therapeutic Effects of Testosterone on Pain Perception in case of Chronic Pain Disorder not-yet-due
Completed, report not yet due 2016-000172-19 Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients with Type 2 Diabetes 2019-01-23 not-yet-due
Ongoing 2016-001554-18 English: Are Antipsychotics Neurotoxic or Neuroprotective? A Randomised Multicentre Longitudinal Study for Comparison of Two Therapy Strategies for the Treatment of Schizophrenia. not-yet-due
Ongoing 2016-003902-14 Intravenous Fish Oil based Lipid Emulsion as Pharmaconutrient Strategy in High-Risk Cardiac Surgery Patients: a Phase II Dosing Study not-yet-due
Completed, but no date 2016-004147-37 Intravenous iron in patients with heart failure and reduced ejection fraction (HFREF) plus iron deficiency: Effects upon phosphate and FGF23 metabolism bad-data
Ongoing 2017-003240-20 Velphoro and impact on the oral cavity and gut microbiome not-yet-due